ArticleCancer prevention research (Philadelphia, Pa.)2026
Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs.
Thomas S Hoang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.